Right Heart Dysfunction clinical trials at University of California Health

1 research study open to eligible people

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
open to eligible people ages 18 years and up
This prospective study is a multi-center early feasibility study assessing the safety and performance of the Aria CV Pulmonary Hypertension System in patients with pulmonary hypertension and right heart dysfunction.
at UCLA UCSD

Our lead scientists for Right Heart Dysfunction research studies include Richard Channick.

Last updated: December 2023

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System